Researchers from Carnegie Mellon University, the University of Pittsburgh, and the University of Washington have revealed a significant feature of Alzheimer’s disease related to the three-dimensional organization of the genome, potentially opening new treatment avenues.
Published in Science, the study highlights how genome folding changes in brain cells of Alzheimer’s patients correlate with shifts in gene activity and brain tissue organization. Utilizing advanced techniques like single-cell technology and a novel deep learning model, the team conducted an in-depth analysis of postmortem samples from the prefrontal cortex.
Key Findings:
-
Understanding Alzheimer’s Complexity:
- Jian Ma, a leading figure in the research, emphasized the need to consider multiple layers of Alzheimer’s pathology, beyond just amyloid plaques and tau tangles. The 3D structure of the genome significantly impacts gene regulation.
-
3D Genome Description:
- Unlike a simple strand, DNA folds into a complex structure that determines gene accessibility. Alterations in this folding can affect cellular function.
-
Techniques Used:
- The team employed GAGE-seq to measure gene expression and genome interactions within individual cells, complemented by spatial transcriptomic maps providing context on gene activity locations.
-
Identification of Changes:
- They discovered that in Alzheimer’s cells, genomic compartments (active/inactive regions) were less distinct, leading to “increased compartment mingling.” This structural change was linked to reduced gene activity and disrupted cellular functions, particularly in neurons and immune microglia.
-
Role of AI:
- The study utilized Hicformer, an AI model, to predict gene activity based on genome structure. This tool demonstrated consistent patterns of 3D genome reorganization tied to Alzheimer’s.
-
Future Directions:
- The findings suggest new regulatory regions could be targeted for therapeutic interventions in future studies.
Research Support:
The study received backing from the National Institutes of Health and involved collaborations from various prestigious institutions.
This research paves the way for understanding the intricate biological components of Alzheimer’s, potentially leading to novel treatment strategies aimed at rectifying genomic structural alterations.
